Catherine A. Sohn is Director of Altimmune, Inc.. Currently has a direct ownership of 1,000 shares of ALT, which is worth approximately $5,320. The most recent transaction as insider was on Mar 17, 2025, when has been sold 1,000 shares (Common Stock, par value $0.0001) at a price of $5.78 per share, resulting in proceeds of $5,780. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1K
n/a 3M change
n/a 12M change
Total Value Held $5,320

Catherine A. Sohn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2025
BUY
Open market or private purchase
$5,780 $5.78 p/Share
1,000 Added 50.0%
1,000 Common Stock, par valu...

Also insider at

JAZZ
Jazz Pharmaceuticals plc Healthcare
LNDC
LANDEC CORP \CA\ Healthcare
AXLA
Axcella Health Inc. Healthcare
RUBY
Rubius Therapeutics, Inc. Healthcare
CAS

Catherine A. Sohn

Director
Dublin 4, L2

Track Institutional and Insider Activities on ALT

Follow Altimmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALT shares.

Notify only if

Insider Trading

Get notified when an Altimmune, Inc. insider buys or sells ALT shares.

Notify only if

News

Receive news related to Altimmune, Inc.

Track Activities on ALT